Prognostic value of a 25-gene assay in patients with gastric cancer after curative resection

[1]  C. Chien,et al.  Sialic acid rescues repurified lipopolysaccharide-induced acute renal failure via inhibiting TLR4/PKC/gp91-mediated endoplasmic reticulum stress, apoptosis, autophagy, and pyroptosis signaling. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[2]  Hongwei Zhang,et al.  MicroRNAs in gastrointestinal cancer: prognostic significance and potential role in chemoresistance , 2014, Expert opinion on biological therapy.

[3]  S. Scott,et al.  Pathological factors affecting gastric adenocarcinoma survival in a Caribbean population from 2000-2010. , 2014, World journal of gastrointestinal surgery.

[4]  M. Qiao,et al.  Tumor suppressor XAF1 induces apoptosis, inhibits angiogenesis and inhibits tumor growth in hepatocellular carcinoma , 2014, Oncotarget.

[5]  S. Hekimi,et al.  The Intrinsic Apoptosis Pathway Mediates the Pro-Longevity Response to Mitochondrial ROS in C. elegans , 2014, Cell.

[6]  R. Tothill,et al.  A Signature Predicting Poor Prognosis in Gastric and Ovarian Cancer Represents a Coordinated Macrophage and Stromal Response , 2014, Clinical Cancer Research.

[7]  M. Dawson,et al.  NF-κB p65 recruited SHP regulates PDCD5-mediated apoptosis in cancer cells , 2013, Apoptosis.

[8]  Yuan Zhao,et al.  Converting a Microarray Signature into a Diagnostic Test: A Trial of Custom 74 Gene Array for Clarification and Prediction the Prognosis of Gastric Cancer , 2013, PloS one.

[9]  Jian Lu,et al.  Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. , 2013, The Lancet. Oncology.

[10]  Zhi Yan,et al.  Identification of a 5-gene signature for clinical and prognostic prediction in gastric cancer patients upon microarray data , 2013, Medical Oncology.

[11]  W. J. Zheng,et al.  Molecular Profiling of Multiple Human Cancers Defines an Inflammatory Cancer-Associated Molecular Pattern and Uncovers KPNA2 as a Uniform Poor Prognostic Cancer Marker , 2013, PloS one.

[12]  Jia Wei,et al.  A three-gene signature as potential predictive biomarker for irinotecan sensitivity in gastric cancer , 2013, Journal of Translational Medicine.

[13]  Biao He,et al.  A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies , 2012, The Lancet.

[14]  Deepti Gadi,et al.  Sequestration of phosphoinositides by mutated MARCKS effector domain inhibits stimulated Ca2+ mobilization and degranulation in mast cells , 2011, Molecular biology of the cell.

[15]  Y. Ohashi,et al.  Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  R. Coler,et al.  Transcriptional profiling of TLR-4/7/8-stimulated guinea pig splenocytes and whole blood by bDNA assay. , 2011, Journal of immunological methods.

[17]  Jae Yong Cho,et al.  Gene Expression Signature–Based Prognostic Risk Score in Gastric Cancer , 2011, Clinical Cancer Research.

[18]  V. Zagonel,et al.  Advanced gastric cancer (GC) and cancer of the gastro-oesophageal junction (GEJ): focus on targeted therapies. , 2011, Critical reviews in oncology/hematology.

[19]  John D. Minna,et al.  Nuclear Receptor Expression Defines a Set of Prognostic Biomarkers for Lung Cancer , 2010, PLoS medicine.

[20]  S. Vowler,et al.  A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia. , 2010, Gastroenterology.

[21]  S. Störkel,et al.  Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  Kay Washington,et al.  7th Edition of the AJCC Cancer Staging Manual: Stomach , 2010, Annals of surgical oncology.

[23]  S. Seno,et al.  Gene Expression Profile Prospectively Predicts Peritoneal Relapse After Curative Surgery of Gastric Cancer , 2010, Annals of Surgical Oncology.

[24]  Y. Shu,et al.  Gene expression profile towards the prediction of patient survival of gastric cancer. , 2009, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[25]  Y. Murakumo,et al.  Nucleolin modulates the subcellular localization of GDNF-inducible zinc finger protein 1 and its roles in transcription and cell proliferation. , 2007, Experimental cell research.

[26]  Alessandro Ambrosi,et al.  Gene Expression Profile of Primary Gastric Cancer: Towards the Prediction of Lymph Node Status , 2007, Annals of Surgical Oncology.

[27]  Jeremy J. W. Chen,et al.  A five-gene signature and clinical outcome in non-small-cell lung cancer. , 2007, The New England journal of medicine.

[28]  Aiguo Zhang,et al.  A multiplex branched DNA assay for parallel quantitative gene expression profiling. , 2006, Analytical biochemistry.

[29]  H. Lage.  Molecular Analysis of Therapy Resistance in Gastric Cancer , 2003, Digestive Diseases.

[30]  Rui Li,et al.  Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines , 2002, Oncogene.

[31]  T. Vogt,et al.  Identification, expression analysis, and mapping of B3galt6, a putative galactosyl transferase gene with similarity to Drosophila brainiac , 2001, Mammalian Genome.

[32]  S. Safe,et al.  Interactions of nuclear receptor coactivator/corepressor proteins with the aryl hydrocarbon receptor complex. , 1999, Archives of biochemistry and biophysics.

[33]  J. Barkin,et al.  Stomach , 2015, The American Journal of Gastroenterology.

[34]  E. Chiorean.  Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial , 2012 .

[35]  PhD Kay Washington MD.  7th Edition of the AJCC Cancer Staging Manual: Stomach , 2010, Annals of Surgical Oncology.